The nomination process and other details about the award located on the AACR Website at http://www.aacr.org . The deadline for nominations is Friday, September 17, 2004.
The award is intended to honor an individual scientist for his or her highly original research. In order to be eligible, candidates must be recently published, active researchers, working in academia, industry or government anywhere in the world.
The winner will give an award lecture during the 96th AACR Annual Meeting in Anaheim, Calif., April 16-20, 2005, and will officially receive the award of €75,000 and a commemorative plaque at a May 2005 ceremony in Trento, Italy, where the Pezcoller Foundation is located.
Past recipients of the Pezcoller Foundation-AACR International Award for Cancer Research are:
2004:
Stanley J. Korsmeyer, M.D.
Sidney Farber Professor of Pathology and Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass.
Investigator, Howard Hughes Medical Institute
2003:
Mario R. Capecchi, Ph.D.
Distinguished Professor and Co-chairman
Eccles Institute of Human Genetics
University of Utah, Salt Lake City
2002:
Carl-Henrik Heldin, Ph.D.
Director, Ludwig Institute for Cancer Research
Professor of Molecular Cell Biology
Uppsala University, Uppsala, Sweden
The Pezcoller Foundation was established in 1982 by Professor Alessio Pezcoller, a dedicated Italian surgeon who made important contributions to medicine during his career and who, through his foresight, vision, and generous gift in support of the formation of the Foundation, stimulated others to make significant advances in cancer research. The Foundation sponsors a series of symposia and publishes a journal. In the past, the Pezcoller Foundation gave a biennial award for contributions to cancer and cancer-related biomedical science in collaboration with the European School of Oncology. The Pezcoller Foundation-AACR International Award builds upon this tradition
Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 22,000 laboratory and clinical scientists engaged in basic, translational, and clinical cancer research in the United States and over 60 other countries. The AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). The AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational, and clinical cancer research.